Collectively, these findings provide important insights into the molecular mechanisms through which MMR-deficiency contributes to GI tumorigenesis and implicate a novel association between TLE6 isoforms and antagonism of RUNX target gene expression in CRC tumor progression. This evidence concerns the gene MRC1 and colorectal carcinoma.